Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Cortex. 2018 Jan 2;99:358–374. doi: 10.1016/j.cortex.2017.12.021

Figure 5.

Figure 5

Tau-PET SUVrs (x-axis) and the associated top 20 AUROCS (y-axis), ranked from highest to lowest AUROC (value listed in the right side of each panel), for controls against PPAOSa patients. Note: A * by AUROC value denotes those whose 95% confidence interval excludes 0.5. A * by region name indicates significant differences (p < .05, adjusted for multiple comparisons) on Wilcoxon rank sum test; p-value is provided. Analysis was repeated after excluding the outlier noted in the Precentral_L ROI effect; the results are unchanged.